menu
    • menu

    Looking for excipients offered by The Dow Chemical Company? Find information on The Dow Chemical Company's regulatory filings (DMFs), cGMP inspections, pricing availability, etc. on PharmaCompass.

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-08-11

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dow Pharma & Medical is a global leader in research, manufacturing and innovation of functional excipients, API’s and silicon-based technologies for medical device fabrication and pharmaceutical processing. It has the material science expertise and global market and regulatory experience to help customers deliver innovative solutions for healthcare challenges of today and tomorrow; bringing new products to market faster and ...
    Dow Pharma & Medical is a global leader in research, manufacturing and innovation of functional excipients, API’s and silicon-based technologies for medical device fabrication and pharmaceutical processing. It has the material science expertise and global market and regulatory experience to help customers deliver innovative solutions for healthcare challenges of today and tomorrow; bringing new products to market faster and extending product life-cycles.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    The Dow Chemical CompanyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2030 Dow Center, Midland, MI 48674
    Telephone
    Telephone
    +1 800 447 4369
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pharma.dupont.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dow-chemical
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI Korea

    Not Confirmed

    envelop Contact Supplier

    CPhI Korea

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    "50 Years of Innovation: Mikart

    mic"50 Years of Innovation: Mikart's legacy and what's next in CDMO excellence"

    This week, SpeakPharma interviews Michael Kallelis, CEO of Mikart, a leading contract development and manufacturing organization (CDMO) celebrating its 50th anniversary in the pharmaceutical industry. Based in the United States, Mikart has built a reputation for technical expertise, flexible business terms, and specialized capabilities in pharmaceutical development services. In this exclusive interview, Kallelis discusses how Mikart maintains its competitive edge through its Pharmaceutical Development Services team, quality control framework, and commitment to customized business solutions. Kallelis also explores the company's focus on liquid suspensions manufacturing, driven by growing demand from aging populations and pediatric patients, and explains how Mikart balances traditional family business values with modern innovation. HIGHLIGHTS// celebrating its 50th anniversary/ reputation for technical expertise/ how Mikart maintains its competitive edge Mikart is celebrating 50 years in business this year — what are some of the major milestones that have shaped the company's journey? Over our 50-year history, we've celebrated many memorable milestones, but one of the most significant in recent years has been achieving our growth objectives. This success was driven by the strategic expansion of our Pharmaceutical Development Services team, the completion of full aggregate serialization in our packaging department, modernization of our IT systems, enhanced productivity, and our ability to attract both new and returning customers. HIGHLIGHTS// expansion of our Pharmaceutical Development Services team/ completion of full aggregate serialization/ attract both new and returning customers How has Mikart maintained its competitive edge in a constantly evolving pharmaceutical landscape? Our customers consistently tell us that what sets us apart is our technical expertise, high service level, and flexible, customized business terms. At the core of our competitiveness is our focus on Pharmaceutical Development Services (PDS). Mikart's PDS opinion leaders are actively engaged in business development and form early, collaborative relationships with our customers' technical teams. From the outset, our prospects and clients work directly with Mikart's experienced formulation chemists, analytical method developers, and process-oriented engineers to design robust, reproducible, and efficient processes. This hands-on development approach is supported by a comprehensive quality control testing framework — covering raw material testing, in-process checks, on-site microbiological testing, and in-house stability studies. Oversight is provided by our robust Quality Management System, managed by a dedicated Quality Assurance and Regulatory Affairs team. The result is disciplined problem-solving, timely FDA submissions, and a "right-first-time" philosophy that accelerates time-to-market. We operate with a strong sense of urgency and consistently deliver a high level of customer satisfaction. What truly differentiates Mikart is our commitment to customized business terms that eliminate common roadblocks seen with other CDMOs. Our secret sauce is our exceptional service and flexibility in helping our customers bring innovative medicines to patients. HIGHLIGHTS// technical expertise, high service level/ flexible, customized business terms/ comprehensive quality control testing framework/ dedicated Quality Assurance and Regulatory Affairs team/ timely FDA submissions/ accelerates time-to-market What capabilities or services does Mikart offer today that didn't exist 10 or 20 years ago? Mikart was an early leader in serialization, implementing full capabilities well ahead of the industry timeline. This proactive approach has kept our packaging team in high demand. We also upgraded our tablet compression equipment to enhance both speed and reliability. To support growing development needs, we invested in new lab-scale development equipment, unit dose cup filling, sachet packaging, low-humidity suites, and a brand-new suite dedicated to closed-system manufacturing of liquids and suspensions. Most recently, we launched a multi-million dollar expansion of our packaging lines to support higher-speed tablet filling, powder-in-bottle formats, and new liquid fill capabilities. HIGHLIGHTS// early leader in serialization/ upgraded our tablet compression equipment/ multi-million dollar expansion of our packaging lines Why are liquid suspensions becoming such a key focus, and how is Mikart positioned? Formulating suspensions is a complex process that requires specialized expertise and equipment. According to our customers, few mid-market CDMOs do it well — and Mikart is one of them. There is growing industry demand for high-quality suspension manufacturing, driven by the needs of the aging baby boomer population and pediatric patients. For both groups, swallowing tablets or capsules can be difficult, making oral liquid suspensions a more practical alternative. In addition to being easier to administer, suspensions offer pharmacological advantages and can improve dosing compliance. Enhanced flavoring techniques further improve the patient experience — especially for children and infants — by making medicines more palatable. HIGHLIGHTS// growing industry demand for high-quality suspension manufacturing/ suspensions offer pharmacological advantages/ improve dosing compliance How does Mikart balance tradition with innovation to meet modern customer demands? At Mikart, we work hard to preserve the values of a traditional family business, even as we continue to modernize. Our goal is to make every customer feel like they are our top priority. Each customer is supported by a dedicated project manager who serves as their primary point of contact, along with direct access to key team members across departments. This structure ensures our customers are never isolated from our subject matter experts and can get timely, accurate answers to their questions. We're also mindful of the "technology trap" — the tendency to pursue every new innovation at the expense of focus and efficiency. Instead, we rely on market data and customer trends to guide our investments, enabling us to concentrate our resources and capital on technologies that meet real market needs. HIGHLIGHTS// customer is supported by a dedicated project manager/ customers are never isolated from our subject matter experts/ we rely on market data and customer trends to guide our investments/ meet real market needs Looking ahead, what's in store for Mikart in the next 5-10 years? Mikart's strategic plan is now in full motion, and with the momentum we've built, 50 percent growth is within reach. This projection is backed by a strong pipeline of annual FDA filings, a growing customer base, and a robust portfolio of active Pharmaceutical Development Services projects. As we grow, we remain committed to delivering exceptional service and continuously evolving to meet the changing needs of our customers. With renewed political emphasis on domestic manufacturing for the US market, we are ideally positioned to support the rapid, cost-effective development and production of high-quality medicines here at home. As we approach our 50th anniversary in the CDMO industry, we celebrate our legacy and look forward with optimism to the opportunities ahead in the next 5 to 10 years. HIGHLIGHTS// 50 percent growth is within reach/ strong pipeline of annual FDA filings 

    Impressions: 2234

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence

    PharmaCompass
    17 Jul 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaQuality, Reliability, TrustQuality, Reliability, Trust

    Quality, Reliability, Trust
    Quality, Reliability, Trust

    reelQuality, Reliability, Trust

    This PharmaReel highlights Rochem’s capabilities in sourcing and supplying Generic APIs and Excipients, driven by Quality, Reliability, and Trust through fully cGMP-compliant operations. With over 30 years of experience and 16 offices worldwide, Rochem continues to develop partnerships across the US, China, Europe, and South America.

    Impressions: 2712

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

    CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

    During the second quarter (Q2) of 2025, contract development and manufacturing organizations (CDMOs) made substantial investments in specialized therapeutic manufacturing. The quarter also saw CDMOs pursue high-value, complex manufacturing niches, particularly in antibody-drug conjugates (ADCs), cell and gene therapies (CGTs) and oligonucleotides.Alongside these trends, Q2 also saw CDMOs strengthen their footprint in the United States amid concerns over rising tariffs and unpredictable trade policies being enforced by the Trump administration.Regeneron Pharmaceuticals committed over US$ 3 billion through a 10-year agreement with Fujifilm Diosynth Biotechnologies to nearly double its US manufacturing capacity for biologics. Under this agreement, Fujifilm will manufacture and supply drug products for Regeneron at its large-scale facility in Holly Springs, North Carolina.Thermo Fisher Scientific announced plans to invest an additional US$ 2 billion in the US over four years, reinforcing its manufacturing and R&D capabilities. With 64 facilities spread across 37 states, Thermo Fisher aims to bolster American innovation and competitiveness. Similarly, Piramal Pharma announced a US$ 90 million investment plan for expanding two facilities in the US, thereby bringing its total investment in the country to US$ 570 million. View CDMO Activity Tracker for Q2 2025 (Free Excel Available)Veranova, Carbogen lead ADC wave; Axplora doubles down on HPAPI production in ItalyThe quarter saw substantial investments in ADC manufacturing. Veranova announced a US$ 20 million investment in bioconjugation development and cGMP manufacturing capacity at its Devens, Massachusetts campus. With this investment, Veranova will be able to provide a more comprehensive suite of services to its partners developing ADCs and other bioconjugates. Veranova’s total investment in the Devens facility now stands at over US$ 50 million. Swiss CDMO Carbogen announced a US$ 31 million co-investment with an unnamed Japanese investor to expand its capabilities across its Aarau and Neuland (Switzerland) facilities. The facility will address increasing demand for complex and high-value compounds such as ADC drug linkers.Axplora announced a further €35 million (US$ 41 million) expansion of its Farmabios site in Italy, doubling the facility to approximately 108,000 square meters by mid-2026. This investment raises its total spend on the site to over €80 million (US$ 94.05 million) since 2019, supporting the production of highly potent active pharmaceutical ingredients (HPAPIs). Farmabios now stands as a key hub in Axplora’s global CDMO network.Polish pharmaceutical manufacturer Polfa Tarchomin is positioning itself as a significant player in the European CDMO market through its investment in the Center for Development and Production of Highly Potent Drugs. This 12,000 square meter facility has two state-of-the-art production lines designed for filling vials and pre-filled syringes with an annual capacity of 26 million product units.Skyepharma’s projected annual revenues from oncology-linked activities touched €10 million (US$ 11.2 million). The CDMO’s facility in Saint-Quentin-Fallavier is equipped to handle cytotoxic and cytostatic compounds, and is one of the few facilities in France capable of managing HPAPIs for oral anticancer treatments. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Athena acquires Medipha Santé, Famar buys MiP Pharma’s German site to strengthen European footprintDuring the quarter, several CDMOs enhanced their strategic capabilities through M&As. Athena Pharmaceutiques acquired  Medipha Santé to build a fully integrated pharmaceutical services platform in Europe. Based in Paris, Athena has strengthened its commercial and regulatory toolbox by bringing aboard Medipha Santé’s 35-strong team, which supports over 100 partner organizations and files approximately 350 dossiers annually with ANSM and other European agencies. With this integration, Athena positions itself as a one-stop CDMO partner.With the acquisition of MiP Pharma’s sterile manufacturing site in Homburg, Germany, the Famar Group has expanded its capabilities in aseptic and lyophilized fill-and-finish operations. The acquisition has strengthened Famar’s position in sterile drug manufacturing. The CDMO now has seven manufacturing facilities in Europe.PCI Pharma Services’ acquisition of Ajinomoto Althea has established a world-class, large-scale manufacturing hub in the San Diego region with state-of-the-art aseptic facilities for prefilled syringes, cartridges and high-potent formulations such as ADCs. PCI Pharma is now amongst the few US-based CDMOs capable of comprehensive ADC manufacturing.Samsung Biologics’ strategic spinoff of its biosimilar business stood out as a significant corporate restructuring exercise during the quarter. The separation of Samsung Bioepis, tentatively renamed Samsung Epis Holdings, aims to enhance Samsung Biologics’ strategic focus and build client trust, as it eliminates potential conflicts between CDMO services and proprietary drug development. The move came after Samsung Biologics inked a contract worth 737.3 billion Korean won (US$ 518 million) with an undisclosed US pharmaceutical company.WuXi Biologics announced a US$ 167 million divestment of its German facility to Terumo and broke ground on a microbial production plant in China. National Resilience, which was launched five years ago as the US drug manufacturer dedicated to broadening access to medicines and protecting biopharma supply chains, said it is shuttering six of its 10 facilities. The company said the sites were “not being fully utilized.” View CDMO Activity Tracker for Q2 2025 (Free Excel Available) MilliporeSigma, Simtra form 5-year ADC alliance; Silexion partners Catalent for siRNA developmentMerck KGaA’s MilliporeSigma and Simtra struck a five-year strategic alliance, combining expertise across the ADC value chain to reduce development timelines and complexity for biopharmaceutical companies. Viralgen collaborated with Trogenix to rapidly scale product supply for TGX-007, an AAV gene therapy for glioblastoma (a type of cancer of the brain and spinal cord).  Silexion announced a collaboration with Catalent for small interfacing RNA (siRNA) development and manufacturing. Catalent’s Limoges (France) facility will conduct formulation development and clinical manufacturing for Silexion’s SIL204 candidate, supporting both systemic and intra-tumoral delivery formulations.Skyepharma’s collaboration with Eneapharm through the Skyehub platform aims to support the treatment of patients suffering from exocrine pancreatic insufficiency, including those affected by cystic fibrosis or pancreatic cancer. Orion Corporation reached an agreement with Shilpa Biocare for the distribution of recombinant human albumin in Europe.Meanwhile, Aenova announced the launch of its Aenovation program, an initiative designed to fast-track early development of pharmaceutical formulations. The program addresses the critical challenges of bioavailability and time-to-market faced by poorly soluble drug candidates. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Our view The quarter saw CDMO developments mimic the broader trends in the pharmaceutical industry, such as onshoring of critical manufacturing capabilities in the US, consolidation of specialized expertise through strategic partnerships, and the relentless focus on emerging therapeutic modalities that promise to transform patient care. With CDMOs continuing to invest in next-generation manufacturing capabilities, we expect the sector to play a crucial role in drug innovation. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 7120

    https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint

    #PharmaFlow by PHARMACOMPASS
    10 Jul 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    WHO warns of falsified cough syrup ingredients seized in Pakistan
    WHO warns of falsified cough syrup ingredients seized in Pakistan

    16 Apr 2024

    // REUTERS

    https://www.reuters.com/world/asia-pacific/who-warns-falsified-cough-syrup-ingredients-seized-pakistan-2024-04-15/

    REUTERS
    16 Apr 2024
    Share Share
    UK: EPO Oppositions Newsletter - Surge In Oppositions Matches Surge In Grants
    UK: EPO Oppositions Newsletter - Surge In Oppositions Matches Surge In Grants

    26 Mar 2020

    // David Lewin MONKAQ

    https://www.mondaq.com/uk/Intellectual-Property/719168/EPO-Oppositions-Newsletter--Surge-In-Oppositions-Matches-Surge-In-Grants

    David Lewin MONKAQ
    26 Mar 2020
    Share Share
    Takeda's Shire Takeover Seen Facing EU Scrutiny of Drug Research
    Takeda's Shire Takeover Seen Facing EU Scrutiny of Drug Research

    09 May 2018

    // Aoife White BLOOMBERG

    https://www.bloomberg.com/news/articles/2018-05-08/takeda-s-shire-takeover-seen-facing-eu-scrutiny-of-drug-research

    Aoife White BLOOMBERG
    09 May 2018
    Share Share
    Dow's Merck Does An About-Face, Releases Cancer Trial Results
    Dow's Merck Does An About-Face, Releases Cancer Trial Results

    16 Jan 2018

    // INVESTORS

    https://www.investors.com/news/technology/dows-merck-does-an-about-face-releases-cancer-trial-results/

    INVESTORS
    16 Jan 2018
    Share Share
    DowDuPont completes FMC acquisition, bolsters excipient biz
    DowDuPont completes FMC acquisition, bolsters excipient biz

    06 Nov 2017

    // Dan Stanton IN PHARMATECHNOLOGIST

    https://www.in-pharmatechnologist.com/Article/2017/11/07/DowDuPont-completes-FMC-acquisition-bolsters-excipient-biz

    Dan Stanton IN PHARMATECHNOLOGIST
    06 Nov 2017
    Share Share
    Continuous Mfg : suitable excipients & more knowledge required, says Dow
    Continuous Mfg : suitable excipients & more knowledge required, says Dow

    25 Oct 2017

    // Flora Southey IN PHARMATECHNOLOGIST

    https://www.in-pharmatechnologist.com/Article/2017/10/25/Continuous-manufacturing-suitable-excipients-more-knowledge-required-says-Dow

    Flora Southey IN PHARMATECHNOLOGIST
    25 Oct 2017
    Share Share

    JDMF

    read-more
    read-more

    01

    DOW CORNING Q7-9120 Silicone Fluid 350cS...

    JDMF

    AGGSpend
    Not Confirmed
    arrow

    02

    DUOLITETM AP143 / 1083, Cholestyramine

    JDMF

    AGGSpend
    Not Confirmed
    arrow

    03

    LiveoTM　Q7-2243 LVA, Simeticone USP

    JDMF

    AGGSpend
    Not Confirmed
    arrow

    04

    LiveoTM　Q7-9120 Silicone Fluid, 100 cS...

    JDMF

    AGGSpend
    Not Confirmed
    arrow

    05

    LiveoTM　Q7-9120 Silicone Fluid, 350 cS...

    JDMF

    AGGSpend
    Not Confirmed
    arrow

    06

    Poly (ethylene oxide)

    JDMF

    AGGSpend
    Not Confirmed
    arrow

    Poly (ethylene oxide)

    U.S.A
    arrow
    AGGSpend
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    The Dow Chemical Company

    Registration Number : 218MF20001

    Registrant's Address : 2211 H. H. Dow Way, Midland MI 48674, United States

    Initial Date of Registration : 2006-02-23

    Latest Date of Registration : 2023-06-21

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    XUS43598-SMA Ca

    JDMF

    AGGSpend
    Not Confirmed
    arrow

    XUS43598-SMA Ca

    U.S.A
    arrow
    AGGSpend
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    The Dow Chemical Company

    Registration Number : 229MF10051

    Registrant's Address : 2-11-1 Nagatacho, Chiyoda-ku, Tokyo

    Initial Date of Registration : 2017-02-22

    Latest Date of Registration : 2017-02-22

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    XUS43598-SMA Na

    JDMF

    AGGSpend
    Not Confirmed
    arrow

    XUS43598-SMA Na

    U.S.A
    arrow
    AGGSpend
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    The Dow Chemical Company

    Registration Number : 229MF10039

    Registrant's Address : 2-11-1 Nagatacho, Chiyoda-ku, Tokyo

    Initial Date of Registration : 2017-02-15

    Latest Date of Registration : 2017-02-15

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    XUS43598SF Ca

    JDMF

    AGGSpend
    Not Confirmed
    arrow

    XUS43598SF Ca

    U.S.A
    arrow
    AGGSpend
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    The Dow Chemical Company

    Registration Number : 306MF10064

    Registrant's Address : 2-11-1 Nagatacho, Chiyoda-ku, Tokyo

    Initial Date of Registration : 2024-05-08

    Latest Date of Registration : 2024-05-08

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    USDMF

    read-more
    read-more

    01

    AFFINISOL™ HYDROXYPROPYL M...

    AGGSpend
    Not Confirmed
    arrow

    02

    AMBERLITE IR-120

    AGGSpend
    Not Confirmed
    arrow

    03

    AMBERLITE IRA-68

    AGGSpend
    Not Confirmed
    arrow

    04

    AMBERLITE IRA-958

    AGGSpend
    Not Confirmed
    arrow

    05

    AMBERLITE IRP-64

    AGGSpend
    Not Confirmed
    arrow

    06

    AMBERLITE IRP-88 POLACRILIN ...

    AGGSpend
    Not Confirmed
    arrow

    07

    AMBERLITE IRP64

    AGGSpend
    Not Confirmed
    arrow

    08

    AMBERLITES IRC-50 & XE 64

    AGGSpend
    Not Confirmed
    arrow

    09

    CARBOWAX SENTRY METHOXYPOLYE...

    AGGSpend
    Not Confirmed
    arrow

    10

    DOW CORNING BIO-PSA AMINE-CO...

    AGGSpend
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Hypromellose

    U.S.A
    AGGSpend
    Not Confirmed
    arrow

    Hypromellose

    U.S.A
    arrow
    AGGSpend
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    The Dow Chemical Company

    Certificate Numbers : R1-CEP 2000-006 - Rev 01

    Status : Withdrawn by Holder

    Issue Date : 2011-01-05

    Type : Chemical

    Substance Number : 348

    blank

    Excipients Web Link

    Market Place

    02

    Macrogols, Types 3350 and 4000

    U.S.A
    AGGSpend
    Not Confirmed
    arrow

    03

    Methylcellulose

    U.S.A
    AGGSpend
    Not Confirmed
    arrow
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KDMF

    read-more
    read-more

    01

    AGGSpend
    Not Confirmed

    01

    Polyethylene glycol 3350

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    arrow
    AGGSpend
    Not Confirmed

    Union Carbide Corporation

    Registrant Name : Ace Biopharm Co., Ltd.

    Registration Date : 2021-12-02

    Registration Number : 20210517-211-J-832(1)

    Manufacturer Name : Union Carbide Corporation

    Manufacturer Address : 355 Louisiana Highway, 3142, ...

    KDMF
    ✖

    Registrant Name : Ace Biopharm Co., Ltd.

    Registration Date : 2021-12-02

    Registration Number : 20210517-211-J-832(1)

    Manufacturer Name : Union Carbide Corporation

    Manufacturer Country : U.S.A

    Manufacturer Address : 355 Louisiana Highway, 3142, Hahnville LA 70057 USA
    blank

    Excipients Web Link

    Market Place

    02

    AGGSpend
    Not Confirmed

    02

    Polyethylene glycol 3350

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    arrow
    AGGSpend
    Not Confirmed

    Union Carbide Corporation

    Registrant Name : Taejun Pharmaceutical Co., Ltd.

    Registration Date : 2021-05-17

    Registration Number : 20210517-211-J-832

    Manufacturer Name : Union Carbide Corporation

    Manufacturer Address : 355 Louisiana Highway, 3142, ...

    KDMF
    ✖

    Registrant Name : Taejun Pharmaceutical Co., Ltd.

    Registration Date : 2021-05-17

    Registration Number : 20210517-211-J-832

    Manufacturer Name : Union Carbide Corporation

    Manufacturer Country : U.S.A

    Manufacturer Address : 355 Louisiana Highway, 3142, Hahnville LA 70057 USA
    blank

    Excipients Web Link

    Market Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    NDC API

    read-more
    read-more

    01

    POLYETHYLENE GLYCOL 3350

    U.S.A
    AGGSpend
    Not Confirmed
    arrow

    POLYETHYLENE GLYCOL 3350

    U.S.A
    arrow
    AGGSpend
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Union Carbide Corporation

    NDC Package Code : 59044-0005

    Start Marketing Date : 2016-09-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (22.7kg/22.7kg)

    Marketing Category : BULK INGREDIENT

    blank

    Excipients Web Link

    Market Place

    02

    POLYETHYLENE GLYCOL 3350

    U.S.A
    AGGSpend
    Not Confirmed
    arrow

    POLYETHYLENE GLYCOL 3350

    U.S.A
    arrow
    AGGSpend
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Union Carbide Corporation

    NDC Package Code : 59044-0015

    Start Marketing Date : 2018-06-21

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Excipients Web Link

    Market Place

    03

    POLYETHYLENE GLYCOL 3350

    U.S.A
    AGGSpend
    Not Confirmed
    arrow

    POLYETHYLENE GLYCOL 3350

    U.S.A
    arrow
    AGGSpend
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Union Carbide Corporation

    NDC Package Code : 59044-0025

    Start Marketing Date : 2000-04-03

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (907kg/907kg)

    Marketing Category : BULK INGREDIENT

    blank

    Excipients Web Link

    Market Place

    04

    POLYETHYLENE GLYCOL 4000

    U.S.A
    AGGSpend
    Not Confirmed
    arrow

    POLYETHYLENE GLYCOL 4000

    U.S.A
    arrow
    AGGSpend
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Union Carbide Corporation

    NDC Package Code : 59044-0007

    Start Marketing Date : 2006-03-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (22.7kg/22.7kg)

    Marketing Category : BULK INGREDIENT

    blank

    Excipients Web Link

    Market Place

    05

    POLYETHYLENE GLYCOL 4000

    U.S.A
    AGGSpend
    Not Confirmed
    arrow

    POLYETHYLENE GLYCOL 4000

    U.S.A
    arrow
    AGGSpend
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Union Carbide Corporation

    NDC Package Code : 59044-0017

    Start Marketing Date : 2018-06-21

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Excipients Web Link

    Market Place

    06

    POLYETHYLENE GLYCOL 4000

    U.S.A
    AGGSpend
    Not Confirmed
    arrow

    POLYETHYLENE GLYCOL 4000

    U.S.A
    arrow
    AGGSpend
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Union Carbide Corporation

    NDC Package Code : 59044-0027

    Start Marketing Date : 2006-03-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (907kg/907kg)

    Marketing Category : BULK INGREDIENT

    blank

    Excipients Web Link

    Market Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    Excipients by Ingredients

    Upload your portfolio for free, ask us

    Excipients By applications

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    FDA

    read-more
    read-more

    01

    FDA Audited

    USA
    AGGSpend
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AGGSpend
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-06-01

    The Dow Chemical Company

    City : Hemlock

    State : MI

    Country/Area : U.S.A

    Zip : 48626

    District : DET

    Center : CDRH

    Project Area : Compliance: Devices

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-06-01

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    AGGSpend
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AGGSpend
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2017-01-19

    The Dow Chemical Company

    City : Hahnville

    State : LA

    Country/Area : U.S.A

    Zip : 70057-2611

    District : NOL

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2017-01-19

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    AGGSpend
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AGGSpend
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2017-01-19

    The Dow Chemical Company

    City : Hahnville

    State : LA

    Country/Area : U.S.A

    Zip : 70057-2611

    District : NOL

    Center : CVM

    Project Area : Monitoring of Marketed Animal Dr...

    District Decision : No Action Indicated

    Inspection End Date : 2017-01-19

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    AGGSpend
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AGGSpend
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2015-07-06

    The Dow Chemical Company

    City : Midland

    State : MI

    Country/Area : U.S.A

    Zip : 48667

    District : DET

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2015-07-06

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    AGGSpend
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AGGSpend
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-10-20

    The Dow Chemical Company

    City : Baton Rouge

    State : LA

    Country/Area : U.S.A

    Zip : 70807

    District : NOL

    Center : CFSAN

    Project Area : Technical Assistance: Food and C...

    District Decision : No Action Indicated

    Inspection End Date : 2014-10-20

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    AGGSpend
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AGGSpend
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-08-21

    The Dow Chemical Company

    City : Hahnville

    State : LA

    Country/Area : U.S.A

    Zip : 70057-2611

    District : NOL

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2014-08-21

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    FDA Audited

    USA
    AGGSpend
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AGGSpend
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-04-09

    Union Carbide Corporation

    City : Texas City

    State : TX

    Country/Area : U.S.A

    Zip : 77590

    District : DAL

    Center : CFSAN

    Project Area : Foodborne Biological Hazards

    District Decision : No Action Indicated

    Inspection End Date : 2014-04-09

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    FDA Audited

    USA
    AGGSpend
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AGGSpend
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2014-01-24

    The Dow Chemical Company

    City : Hemlock

    State : MI

    Country/Area : U.S.A

    Zip : 48626

    District : DET

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2014-01-24

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    09

    FDA Audited

    USA
    AGGSpend
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AGGSpend
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2013-02-13

    The Dow Chemical Company

    City : Plaquemine

    State : LA

    Country/Area : U.S.A

    Zip : 70764

    District : NOL

    Center : CFSAN

    Project Area : Colors and Cosmetics Technology

    District Decision : No Action Indicated

    Inspection End Date : 2013-02-13

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    10

    FDA Audited

    USA
    AGGSpend
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AGGSpend
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-02-13

    The Dow Chemical Company

    City : Plaquemine

    State : LA

    Country/Area : U.S.A

    Zip : 70764

    District : NOL

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-02-13

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    EDQM

    read-more
    read-more

    01

    GMP Certified

    EU
    AGGSpend
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    AGGSpend
    Not Confirmed

    The Dow Chemical Company

    Type : GMP Certificates

    Number : 15MPP047HFR...

    EudraGMDP Key : 36564

    Country : France

    Issue Date : 2016-07-29

    Post Code : 02300

    NCA Ref : 552 012 791 ...

    City : CHAUNY

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    GMP Certified

    EU
    AGGSpend
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    AGGSpend
    Not Confirmed

    The Dow Chemical Company

    Type : GMP Certificates

    Number : 15MPP047HFR...

    EudraGMDP Key : 30841

    Country : France

    Issue Date : 2015-08-31

    Post Code : 02300

    NCA Ref : 552 012 791 ...

    City : CHAUNY

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    GMP Certified

    EU
    AGGSpend
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    AGGSpend
    Not Confirmed

    The Dow Chemical Company

    Type : GMP Certificates

    Number : HMP/FR/217/...

    EudraGMDP Key : 11439

    Country : France

    Issue Date : 2011-07-15

    Post Code : 02300

    NCA Ref : 552 012 791 ...

    City : CHAUNY

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    GMP Certified

    EU
    AGGSpend
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    AGGSpend
    Not Confirmed

    The Dow Chemical Company

    Type : GMP Certificates

    Number : 2007/HMP/FR...

    EudraGMDP Key : 5450

    Country : France

    Issue Date : 2007-02-15

    Post Code : 02300

    NCA Ref : 552 012 791 ...

    City : CHAUNY

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact The Dow Chemical Company and get a quotation

    The Dow Chemical Company is a supplier offers 79 products (APIs, Excipients or Intermediates).

    Find a price of Simethicone bulk with DMF, JDMF offered by The Dow Chemical Company

    Find a price of Cholestyramine bulk with JDMF offered by The Dow Chemical Company

    Find a price of Dimethicone bulk with JDMF offered by The Dow Chemical Company

    Find a price of Amberlite Irp69 bulk with DMF offered by The Dow Chemical Company

    Find a price of Cholestyramine bulk with DMF offered by The Dow Chemical Company

    Find a price of Lauromacrogol bulk with JDMF offered by The Dow Chemical Company

    Find a price of Macrogol bulk with DMF offered by The Dow Chemical Company

    Find a price of Simethicone bulk with DMF offered by The Dow Chemical Company

    Find a price of XUS43598SF Ca bulk with JDMF offered by The Dow Chemical Company

    Find a price of XUS43598-SMA Na bulk with JDMF offered by The Dow Chemical Company

    Find a price of XUS43598-SMA Ca bulk with JDMF offered by The Dow Chemical Company

    Find a price of Amberlite Irp69 bulk offered by The Dow Chemical Company

    Find a price of Aspirin bulk offered by The Dow Chemical Company

    Find a price of Cholestyramine bulk offered by The Dow Chemical Company

    Find a price of Cyclopropane bulk offered by The Dow Chemical Company

    Find a price of Dead On Polystyrene bulk offered by The Dow Chemical Company

    Find a price of Decamethylcyclopentasiloxane bulk offered by The Dow Chemical Company

    Find a price of Dextropropoxyphene HCl bulk offered by The Dow Chemical Company

    Find a price of DPPC bulk offered by The Dow Chemical Company

    Find a price of Edetate Sodium bulk offered by The Dow Chemical Company

    Find a price of Erythromycin bulk offered by The Dow Chemical Company

    Find a price of Erythromycin Stearate bulk offered by The Dow Chemical Company

    Find a price of GUANIDINE HYDROCHLORIDE API bulk offered by The Dow Chemical Company

    Find a price of Mesalazine bulk offered by The Dow Chemical Company

    Find a price of Oxygen bulk offered by The Dow Chemical Company

    Find a price of Sevelamer Hydrochloride bulk offered by The Dow Chemical Company

    Find a price of Tetracycline bulk offered by The Dow Chemical Company

    Find a price of Theophylline bulk offered by The Dow Chemical Company

    Find a price of Vinyl Chloride bulk offered by The Dow Chemical Company

    Find a price of Xenon Radioisotopes bulk offered by The Dow Chemical Company

    Find a price of Zoalene bulk offered by The Dow Chemical Company

    Find a price of TROLENE FM MEDICATED PREMIX bulk offered by The Dow Chemical Company

    Find a price of PZ 5561.21 (DURAFILM PRODUCT) bulk offered by The Dow Chemical Company

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN MIDLAND, MICHIGAN. bulk offered by The Dow Chemical Company

    Find a price of CHIMERIC (MURINE VARIABLE, HUMAN CONSTANT) MONOCLONAL ANTIBODY (CC49) TO TUMOR ASSOCIATED GLYCOPROTEIN (TAG)-72 bulk offered by The Dow Chemical Company

    Find a price of SILASTIC 1808 ELASTOMER bulk offered by The Dow Chemical Company

    Find a price of SILICONE X-251 bulk offered by The Dow Chemical Company

    Find a price of DOW 132 (4-TERT-BUTYL-2-CHLOROPHENYLMETHYL METHY PHOSPHORAMIDATE) bulk offered by The Dow Chemical Company

    Find a price of SILASTIC 9711 MEDICAL GRADE ELASTOMER bulk offered by The Dow Chemical Company

    Find a price of MANUF PROCESSES OF CAP-PLATE MENICON & MAFILCON SOFT CONTACT LENS MAT. bulk offered by The Dow Chemical Company

    Find a price of VINYLITE BRAND COATED PAPER VDI 6645 WHITE 1435 bulk offered by The Dow Chemical Company

    Find a price of TEFLURANE bulk offered by The Dow Chemical Company

    Find a price of X7-2837/Q7-2837 SILICONE EMULSION AND REINFORCING AGENT bulk offered by The Dow Chemical Company

    Find a price of SILICONE RUBBER DOW CORNING SILASTIC bulk offered by The Dow Chemical Company

    Find a price of INVESTIGATIONAL DRUG "MASTER FILE" FOR FUTURE REFS NOTICES T/B SUBMITT bulk offered by The Dow Chemical Company

    Find a price of SYNTHETIC SODIUM ALUMINOSILICATE ABSORBENTS (MOLECULAR SIEVES) bulk offered by The Dow Chemical Company

    Find a price of POLYGLYCOL E-3350 NF bulk offered by The Dow Chemical Company

    Find a price of RHOZYME J-25 CONCENTRATE bulk offered by The Dow Chemical Company

    Find a price of HYAMINE 1622 CRYSTALS (BENSETHONIUM CHLORIDE) bulk offered by The Dow Chemical Company

    Find a price of MURINE MONOCLONAL ANTIBODY (COL-1) TO CEA bulk offered by The Dow Chemical Company

    Find a price of BROMINATED SALICYLANILIDE bulk offered by The Dow Chemical Company

    Find a price of PERSONNEL HANDLING NEW DRUG SUBSTANCES bulk offered by The Dow Chemical Company

    Find a price of UNION CARBIDE'S SENTRY SIMETHICONE USP & 30% EMUL bulk offered by The Dow Chemical Company

    Find a price of 20% OXYGEN, 80% ARGON AS MANUF AT TORRENCIE, CA bulk offered by The Dow Chemical Company

    Find a price of PEI 600 POLYETHYLENIMINE bulk offered by The Dow Chemical Company

    Find a price of MONOCLONAL ANTIBODY CC49 bulk offered by The Dow Chemical Company

    Find a price of HYAMINE X (QUATERNARY AMMONIUM CHLORIDE COMPOUND) bulk offered by The Dow Chemical Company

    Find a price of FACILITIES IN SHIZOUKA, JAPAN bulk offered by The Dow Chemical Company

    Find a price of BIO-RELEASE SILICONE RELEASE COATING SYSTEM, HEMLOCK, MI bulk offered by The Dow Chemical Company

    Find a price of BIOCRYL, BPA-1000 bulk offered by The Dow Chemical Company

    Find a price of PROPYLENE GLYCOL--TRADE NAME SIRLENE (VET) bulk offered by The Dow Chemical Company

    Find a price of ETHYCELLULOSE DISPERSIONS bulk offered by The Dow Chemical Company

    Find a price of ZIRCONIA TEXTILES bulk offered by The Dow Chemical Company

    Find a price of ASPERKINASE PRODUCTION bulk offered by The Dow Chemical Company

    Find a price of POLYTHIOL RESIN bulk offered by The Dow Chemical Company

    Find a price of TERGITOL MONIONIC SURFACTANT 12-M-10 bulk offered by The Dow Chemical Company

    Find a price of FACILITIES & CONTROLS (METHOXY FLURANE) bulk offered by The Dow Chemical Company

    Find a price of UCC MASTER MILKER SYSTEM FOR TC-99 EXTRACTION FROM MO-99 bulk offered by The Dow Chemical Company

    Find a price of POLYMER JR & LR RESINS bulk offered by The Dow Chemical Company

    Find a price of VERSENE CA. CALCIUM CHELATING AGENT bulk offered by The Dow Chemical Company

    Find a price of HYDROXYETHYL METHACRYLATE 94% bulk offered by The Dow Chemical Company

    Find a price of DISIDIUM DIHYDROGEN VERSENATE, A.R. bulk offered by The Dow Chemical Company

    Find a price of UNS-TETRAFLUOROETHANE bulk offered by The Dow Chemical Company

    Find a price of ETHOXYLATED POLYETHYLENIMINE, MONTREK 600E bulk offered by The Dow Chemical Company

    Find a price of RHOZYME 41 CONCENTRATE bulk offered by The Dow Chemical Company

    Find a price of BIOCRYL BPA-5050PMN bulk offered by The Dow Chemical Company

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN PITTSBURG, CAL. bulk offered by The Dow Chemical Company

    Find a price of TERGITOL ANIONIC SURFACTANT 4 bulk offered by The Dow Chemical Company

    Find a price of BIOCRYL, BPA-1050 bulk offered by The Dow Chemical Company

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search